India suspends another drugmaker's licence over tainted cough syrup


FILE PHOTO: Indian parliament building is reflected in a puddle after the rain as a man sweeps the water in New Delhi, India July 20, 2018. REUTERS/Adnan Abidi/File Photo

NEW DELHI (Reuters) - India has suspended a drugmaker's manufacturing licence after the World Health Organization flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April, the government told the parliament on Tuesday.

Indian regulators are inspecting drugmakers after cough syrups made in the country were linked to at least 89 child deaths in Gambia and Uzbekistan last year, which has dented India's image as the "pharmacy of the world" providing affordable drugs globally.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

At least 50 children killed in diphtheria outbreak in northwest Nigeria
Feature: Despite hardships, West Bank refugee camp children find hope with Chinese support
Unpaid work in Cabo Verde estimated at 9.6 pct of GDP
Ghanaian expert urges Africa to partner with China for cheaper energy development
External forces may be instigating anti-migrant violence in South Africa, says president
Roundup: Nigerian president orders swift rescue after mass abduction in central state
Belarus begins air defense, air force exercises
1st LD Writethru: Canada announces counter-tariffs on over 700 U.S. goods
2nd LD Writethru: 3 killed in fire at Russian gas chemical complex
Kenya bans entry of pesticides prohibited abroad

Others Also Read